Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl Icosapentate in severe hypertriglyceridemia
NCT04239950Phase 3Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- May 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Epadel in hypertriglyceridemia, sponsored by Mochida Pharmaceutical Co., Ltd.. Started May 2020; status: completed.
02
Drugs
Epadel
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT04239950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04239950.